1,441
+2.13%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Colan Totte Co
Its shares trade on Tokyo Stock Exchange under the ticker 7792.T. It has been listed since 8 July 2021. In the fiscal year to 30 September 2025, it reported revenue of ¥6.92bn and net income of ¥1.33bn. At that date it held total assets of ¥6.74bn and shareholders' equity of ¥5.17bn.
Colan Totte Co., Ltd. engages in the manufacture and sale of medical equipment and healthcare products. The company is headquartered in Osaka, Osaka-Fu. The company went IPO on 2021-07-08. Colantotte is a brand that develops core home-use magnetic therapy devices. The firm operates two businesses, including the Colan Totte business and the CSS business. The Colan Totte business is divided into retail, wholesale, and e-commerce divisions based on sales channels. The retail division sells directly to general consumers at directly managed stores in Japan. The wholesale division consists of a division that sells wholesale to domestic distributors and retailers and a division that sells wholesale to overseas distributors. The e-commerce division sells directly to general consumers through electronic commerce (EC) sites and EC malls.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 8 Jul 2021
- Employees
- 90
- Website
- colantotte.co.jp ↗
Leadership
Pay as last reported
- Mr. Katsumi KomatsuPresident, Chief Executive Officer, Representative Director, since 2002
- Ms. Yumiko KomatsuSenior Managing Director, Chief Senior Director of Marketing, since 1997
- Mr. Hitoshi MoritaChief Senior Director of Sales, Director, since 2015
- Mr. Yoshiaki IsakaChief Senior Director of Administration, Director, since 2022
- Mr. Kohei RokutoChief Senior Director of Production, Director, since 2021
- Mr. Aki FujiokaIndependent Director
- Mr. Yuji IsokawaIndependent Director
- Mr. Toshinobu ShimizuIndependent Director
- Mr. Yasushi YanagiboriIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Colan Totte Co Ltd operates in the Health Care sector with 90 employees.
- The Colan Totte brand develops core home-use magnetic therapy devices.
- The company has a dual business structure with Colan Totte and CSS operations.
Weaknesses
- The company's retail division is limited to managed stores in Japan only.
- The wholesale division serves domestic and overseas distributors but lacks specific market data.
- The e-commerce division relies on EC sites and EC malls without unique platforms.
Opportunities
- Expanding the Colan Totte business into overseas markets through wholesale divisions.
- Growing demand for home-use magnetic therapy devices in Japan's aging population.
- Increasing e-commerce sales via direct consumer engagement on EC platforms.
Threats
- Competition from established medical equipment manufacturers in Japan.
- Regulatory changes affecting healthcare product approvals in Japan.
- Economic downturns impacting consumer spending on non-essential health products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.